188 related articles for article (PubMed ID: 15905461)
1. COX-2-derived prostacyclin modulates vascular remodeling.
Rudic RD; Brinster D; Cheng Y; Fries S; Song WL; Austin S; Coffman TM; FitzGerald GA
Circ Res; 2005 Jun; 96(12):1240-7. PubMed ID: 15905461
[TBL] [Abstract][Full Text] [Related]
2. Role of prostacyclin in the cardiovascular response to thromboxane A2.
Cheng Y; Austin SC; Rocca B; Koller BH; Coffman TM; Grosser T; Lawson JA; FitzGerald GA
Science; 2002 Apr; 296(5567):539-41. PubMed ID: 11964481
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenases, thromboxane, and atherosclerosis: plaque destabilization by cyclooxygenase-2 inhibition combined with thromboxane receptor antagonism.
Egan KM; Wang M; Fries S; Lucitt MB; Zukas AM; Puré E; Lawson JA; FitzGerald GA
Circulation; 2005 Jan; 111(3):334-42. PubMed ID: 15655126
[TBL] [Abstract][Full Text] [Related]
4. COX-2-derived prostacyclin confers atheroprotection on female mice.
Egan KM; Lawson JA; Fries S; Koller B; Rader DJ; Smyth EM; Fitzgerald GA
Science; 2004 Dec; 306(5703):1954-7. PubMed ID: 15550624
[TBL] [Abstract][Full Text] [Related]
5. Optimal suppression of thromboxane A(2) formation by aspirin during percutaneous transluminal coronary angioplasty: no additional effect of a selective cyclooxygenase-2 inhibitor.
Kearney D; Byrne A; Crean P; Cox D; Fitzgerald DJ
J Am Coll Cardiol; 2004 Feb; 43(4):526-31. PubMed ID: 14975458
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase isoforms and platelet vessel wall interactions in the apolipoprotein E knockout mouse model of atherosclerosis.
Belton OA; Duffy A; Toomey S; Fitzgerald DJ
Circulation; 2003 Dec; 108(24):3017-23. PubMed ID: 14638539
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin I2 and prostaglandin E2 modulate human intrarenal artery contractility through prostaglandin E2-EP4, prostacyclin-IP, and thromboxane A2-TP receptors.
Eskildsen MP; Hansen PB; Stubbe J; Toft A; Walter S; Marcussen N; Rasmussen LM; Vanhoutte PM; Jensen BL
Hypertension; 2014 Sep; 64(3):551-6. PubMed ID: 24914192
[TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase-2-derived endogenous prostacyclin enhances mouse embryo hatching.
Huang JC; Wun WS; Goldsby JS; Matijevic-Aleksic N; Wu KK
Hum Reprod; 2004 Dec; 19(12):2900-6. PubMed ID: 15489241
[TBL] [Abstract][Full Text] [Related]
9. Roles of cyclooxygenase-2 and prostacyclin/IP receptors in mucosal defense against ischemia/reperfusion injury in mouse stomach.
Kotani T; Kobata A; Nakamura E; Amagase K; Takeuchi K
J Pharmacol Exp Ther; 2006 Feb; 316(2):547-55. PubMed ID: 16236816
[TBL] [Abstract][Full Text] [Related]
10. Oviduct prostacyclin functions as a paracrine factor to augment the development of embryos.
Huang JC; Goldsby JS; Arbab F; Melhem Z; Aleksic N; Wu KK
Hum Reprod; 2004 Dec; 19(12):2907-12. PubMed ID: 15492023
[TBL] [Abstract][Full Text] [Related]
11. A vasoconstrictor role for cyclooxygenase-1-mediated prostacyclin synthesis in mouse renal arteries.
Liu B; Zhang Y; Zhu N; Li H; Luo W; Zhou Y
Am J Physiol Renal Physiol; 2013 Nov; 305(9):F1315-22. PubMed ID: 23986518
[TBL] [Abstract][Full Text] [Related]
12. Estrogen stimulation of COX-2-derived PGI2 confers atheroprotection.
Shah BH
Trends Endocrinol Metab; 2005 Jul; 16(5):199-201. PubMed ID: 15950485
[TBL] [Abstract][Full Text] [Related]
13. COX-2-dependent cardiac failure in Gh/tTG transgenic mice.
Zhang Z; Vezza R; Plappert T; McNamara P; Lawson JA; Austin S; Praticò D; Sutton MS; FitzGerald GA
Circ Res; 2003 May; 92(10):1153-61. PubMed ID: 12702643
[TBL] [Abstract][Full Text] [Related]
14. Cyclo-oxygenase products and atherothrombosis.
FitzGerald GA; Austin S; Egan K; Cheng Y; Pratico D
Ann Med; 2000 Dec; 32 Suppl 1():21-6. PubMed ID: 11209977
[TBL] [Abstract][Full Text] [Related]
15. Decreased susceptibility to renovascular hypertension in mice lacking the prostaglandin I2 receptor IP.
Fujino T; Nakagawa N; Yuhki K; Hara A; Yamada T; Takayama K; Kuriyama S; Hosoki Y; Takahata O; Taniguchi T; Fukuzawa J; Hasebe N; Kikuchi K; Narumiya S; Ushikubi F
J Clin Invest; 2004 Sep; 114(6):805-12. PubMed ID: 15372104
[TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase-2 and inflammation in atherosclerosis.
Linton MF; Fazio S
Curr Opin Pharmacol; 2004 Apr; 4(2):116-23. PubMed ID: 15063354
[TBL] [Abstract][Full Text] [Related]
17. COX-2 inhibitors and metabolism of essential fatty acids.
Das UN
Med Sci Monit; 2005 Jul; 11(7):RA233-7. PubMed ID: 15990700
[TBL] [Abstract][Full Text] [Related]
18. [Specific cyclo-oxygenase-2 inhibitors in cardiovascular pathology].
Monsuez JJ
Arch Mal Coeur Vaiss; 2004 Jun; 97(6):632-40. PubMed ID: 15283037
[TBL] [Abstract][Full Text] [Related]
19. Prostacyclin protects against elevated blood pressure and cardiac fibrosis.
Francois H; Athirakul K; Howell D; Dash R; Mao L; Kim HS; Rockman HA; Fitzgerald GA; Koller BH; Coffman TM
Cell Metab; 2005 Sep; 2(3):201-7. PubMed ID: 16154102
[TBL] [Abstract][Full Text] [Related]
20. Involvement of cyclooxygenase-2 and EP3 prostaglandin receptor in acute herpetic but not postherpetic pain in mice.
Takasaki I; Nojima H; Shiraki K; Sugimoto Y; Ichikawa A; Ushikubi F; Narumiya S; Kuraishi Y
Neuropharmacology; 2005 Sep; 49(3):283-92. PubMed ID: 15925391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
